Evidence supports the use of long-acting injectable (LAI) antipsychotics in the treatment and prevention psychosis, but these formulations remain under-used in the UK. Overall, LAIs offer many advantages and the advent of second-generation LAIs increased interest in injectables as these newer drugs offer similar benefits to their oral equivalents. LAIs should be one of the options discussed with patients requiring long-term treatment.To read the full article, log in using your NHS OpenAthens details